LPL Financial LLC increased its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 20.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 157,769 shares of the financial services provider’s stock after acquiring an additional 26,790 shares during the period. LPL Financial LLC’s holdings in CME Group were worth $36,639,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the stock. Raymond James Financial Inc. acquired a new stake in CME Group in the 4th quarter valued at about $871,063,000. Franklin Resources Inc. lifted its stake in CME Group by 70.4% during the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock valued at $544,157,000 after purchasing an additional 1,003,119 shares during the last quarter. Capital Wealth Planning LLC boosted its holdings in CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after buying an additional 996,498 shares in the last quarter. Egerton Capital UK LLP acquired a new position in CME Group in the fourth quarter worth approximately $223,967,000. Finally, Canoe Financial LP increased its holdings in shares of CME Group by 698.0% in the fourth quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider’s stock valued at $126,384,000 after buying an additional 476,019 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group Trading Up 0.1 %
NASDAQ CME opened at $262.22 on Friday. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $267.91. The firm’s fifty day simple moving average is $249.65 and its 200-day simple moving average is $235.63. The company has a market capitalization of $94.49 billion, a PE ratio of 27.12, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53.
CME Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were paid a $1.25 dividend. The ex-dividend date was Friday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.91%. CME Group’s payout ratio is 51.71%.
CME Group announced that its Board of Directors has authorized a share buyback program on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s management believes its shares are undervalued.
Wall Street Analysts Forecast Growth
CME has been the topic of a number of recent research reports. Royal Bank of Canada lifted their target price on CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a report on Thursday, February 13th. Erste Group Bank raised CME Group to a “strong-buy” rating in a research note on Monday, March 17th. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Raymond James raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price on the stock in a research report on Monday, March 10th. Finally, Oppenheimer upped their price target on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average target price of $238.93.
Check Out Our Latest Stock Analysis on CME
Insiders Place Their Bets
In related news, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Howard J. Siegel sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 over the last ninety days. Corporate insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- Using the MarketBeat Stock Split Calculator
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- A Deeper Look at Bid-Ask Spreads
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Best Stocks Under $10.00
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.